retatrutide peptide triple hormone receptor agonist Medscape | Retatrutide, an investigational that shows promise for weight loss in ongoing phase-3 clinical trials, is retatrutide triple hormone receptor agonist
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26












.jpg)












